Caption Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Caption Management, LLC

$6.13 Billion
Q2 2024

A detailed history of Caption Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 11,300 shares of ARWR stock, worth $216,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,300

Previous 49,000 76.94%

Holding current value

$216,734

Previous $1.4 Million 79.09%

% of portfolio

0.0%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $481,140 - $621,280	22,000 Added 44.9%	71,000 $1.85 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $2,666 - $3,869	98 Added 0.2%	49,000 $1.4 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $1.04 Million - $1.52 Million	48,902 New	48,902 $1.5 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $243,904 - $396,653	10,300 New	10,300 $261,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $62,223 - $101,451	2,100 Added 4.9%	45,000 $1.49 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $415,905 - $757,429	14,966 Added 53.58%	42,900 $1.51 Million
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $314,345 - $555,141	7,934 Added 39.67%	27,934 $1.28 Million
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $548,601 - $779,224	9,444 Added 89.47%	20,000 $1.33 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $1.14 Million - $1.65 Million	-19,444 Reduced 64.81%	10,556 $659,000
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $953,060 - $1.47 Million	28,698 Added 2204.15%	30,000 $1.29 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $34,008 - $56,337	1,302 New	1,302 $55,000
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $168,592 - $517,584	-8,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $230,748 - $598,682	8,200 New	8,200 $520,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

92.3M

Call Options Held

1.33M

Put Options Held

549K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.03B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History